All > American Chronic Pain

Pharmacogenetic Testing for Chronic Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
MedStar Good Samaritan Hospital, Baltimore, MDChronic PainPharmacogenetic Testing - Genetic
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether a personalized medicine approach to prescribing opioids for chronic pain results in better pain control for patients.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Hydrochlorothiazide 12.5mg
1
Standardized Discharge Prescription
1
Panel-based pharmacogenetic genotyping

Study Objectives

1 Primary · 11 Secondary · Reporting Duration: first encounter (baseline visit), 3 months, 12 months

3 months
Change in Ability to Participate in Social Roles and Activities
Change in Anxiety Symptoms
Mental Depression
Change in Fatigue Symptoms
Change in Pain Intensity
Change in Pain Intensity Among Those with Therapy Concordant with PGx Recommendations
Change in Pain Interference Symptoms
Change in Physical Function
Change in Sleep Disturbance
Opioid Use
Significant Change in Pain Intensity
Month 12
Recommendation Acceptance

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Hydrochlorothiazide 12.5mg
1
Standardized Discharge Prescription
1
Panel-based pharmacogenetic genotyping

Trial Design

2 Treatment Groups

Standard care
1 of 2
PGx-guided care
1 of 2

Active Control

Experimental Treatment

315 Total Participants · 2 Treatment Groups

Primary Treatment: Pharmacogenetic Testing · No Placebo Group · N/A

PGx-guided careExperimental Group · 2 Interventions: Pharmacogenetic Testing, Pharmacist Consultation Note · Intervention Types: Genetic, Other
Standard care
Other
ActiveComparator Group · 1 Intervention: Delayed pharmacogenetic testing · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: first encounter (baseline visit), 3 months, 12 months

Who is running the clinical trial?

Medstar Health Research InstituteLead Sponsor
176 Previous Clinical Trials
133,730 Total Patients Enrolled
1 Trials studying Chronic Pain
94 Patients Enrolled for Chronic Pain
Kailos Genetics, Inc.UNKNOWN
Max Smith, PharmDPrincipal InvestigatorMedStar Health

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been experiencing pain for three or more months.

Who else is applying?

What state do they live in?
Maryland100.0%
How old are they?
65+100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%
References

Frequently Asked Questions

Are researchers presently accepting participants for the trial?

"Clinicaltrials.gov confirms that this medical study is actively enlisting patients for participation. It was first made public on December 2nd 2020, and its information has been recently updated on March 1st 2022." - Anonymous Online Contributor

Unverified Answer

What is the aggregate quantity of participants engaging in this research project?

"Affirmative. According to clinicaltrials.gov, this research project is actively searching for participants and first appeared on December 2nd 2020. Currently, 400 people are needed at 1 medical site for the experiment." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top